AXL inhibitors selected by molecular docking: Option for reducing SARS-CoV-2 entry into cellsArticle Published on 2022-04-132023-07-11 Journal: Acta pharmaceutica (Zagreb, Croatia) [Category] COVID19(2023년), [키워드] AXL ligand COVID-19 molecular docking NTD-S1 S protein SARS-CoV-2 [DOI] 10.2478/acph-2022-0024